Lupus Foundation of America,

Oklahoma Chapter, Inc.

This research study will test an investigational new drug to evaluate whether it is safe and effective for people who have been diagnosed with Systemic Lupus Erythematosus.

Study inclusion:

• Are at least 18 years of age.
• Have been diagnosed with Systemic Lupus Erythematosus
• Are receiving corticoid steroids (prednisone or equivalent, 10-20 mg/day)
• Are receiving either an immunosuppressant or antimalarial.

You will not be eligible to participate in this study if you:

• Are a woman who is pregnant or breastfeeding a child.
• Have active severe lupus disease.

For more information contact:

Rhonda Maxey, Head CRC

The Oklahoma Center for Arthritis Therapy & Research, Inc.

2424 E 21st St., Ste 500

Tulsa OK  74114

918-748-8024

[ Home ] [ Up ]

Contact oklupus@flash.net with questions or comments about this web site.